Agoracom: Small Cap Investment - Resverlogix Corp. - Re: ESC 2019 Symposium: Epigenetics: A new pathway to tackle residual risk?

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Back To Forum List View

ESC 2019 Symposium: Epigenetics: A new pathway to tackle residual risk?

BearDownAZ

Jul 05, 2019 04:20PM

Cabel

Rank: Treasurer [?]

Points: 1655 [?]

Votes: 16 Score: 2.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: ESC 2019 Symposium: Epigenetics: A new pathway to tackle residual risk?

in response to

ESC 2019 Symposium: Epigenetics: A new pathway to tackle residual risk?

BearDownAZ

posted on Jul 06, 2019 05:38AM

BDZ,

Can you please elaborate on what Residual Risk means.

It seems to me the only title that stands out is for the CD on July 17,.... that makes it sound like they will talking about actual trial results.

Thanks

2 Recommendations

Re: ESC 2019 Symposium: Epigenetics: A new pathway to tackle residual risk?

BearDownAZ

Jul 06, 2019 12:47PM

Re: ESC 2019 Symposium: Epigenetics: A new pathway to tackle residual risk?

Toinv

Jul 06, 2019 01:53PM

Reply New Message

Back To Forum List View

Please to post a reply